Snoring is the hoarse sound that is produced when air flows past relaxed tissues in throat, giving rise to friction between the tissues that causes vibrations on breathing. Snoring is a common phenomenon found in population, but for some people it could be a serious health condition. Snoring is usually related to a sleep disorder called obstructive sleep apnea (OSA), which is characterized by loud snoring with intervals of silence when breathing stops or nearly stops. The prevalence of sleep apnea in children is around 3%, with the highest frequency between the ages of 2 and 5 years. Snoring can cause several serious health issues especially heart associated ailments including coronary artery disease, atrial fibrillation, stroke systemic hypertension, and anxiety. It is a leading cause for sleep deprivation, which also may be outcome of throat weakness, obesity, and high consumption of alcohol and drugs causing obstruction in the nasal passageway. Snoring however, can be treated or reduced to a bearable extent using nasal surgery or anti-snoring devices. Some changes in lifestyle, such as weight loss, reduction in alcohol intake can help stop snoring.
COVID – 19 scenario analysis:
- The COVID-19 pandemic has emerged as a humanitarian as well as economic crisis, creating strain on the society and affecting millions of people and businesses.
- Industry closures and people are asked to stay in their homes which has cause taken a huge toll in terms of money and economic growth.
- Over 4 million people have been affected globally, with 300,000 losing their lives due to SARS-CoV-2.
- Healthcare organizations are already working in battle mode, preparing new plans to respond growing COVID-19 patients, right from sourcing rapid diagnosing kits to sufficient PPE kits for workers.
- Due to diversion of medical field toward treating COVID-19, the funding to R&D activities related to anti-snoring has been reduced and this segment have to face negligence subsequently causing negative impact on the anti-snoring treatment market.
Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis
Major factors that would drive the market for anti-snoring treatment include high consumption of fast food and unhealthy dietary habits, changing sedentary lifestyle with low levels of physical inactivity, higher intake of alcohol and tobacco smoking. It has been observed that obese people with body mass index (BMI) score more than 30 is a leading factor in growth of sleep disorders and apnea. According to the National Sleep Foundation, snoring has been often observed as a common problem among people of all ages irrespective of gender, affecting over 90 million people in the U.S. only. As a result, rise in the factors having adverse effects on sleep will in turn boost the demand for anti-snoring treatment, thereby, facilitating growth for this market. Heavy expenditure on R&D activities and technological advances would ensure a healthy growth for anti-snoring treatment market. Devices such as the Theravent Nightly Snore Therapy represent developments in snoring treatment, which works on principle of maintaining clear airway during sleep using expiratory positive airway pressure (EPAP). In order to meet the market demand for cost-effective anti-snoring treatment, Primark in February 2019 launched anti-snore pillow to aid in prevention of snoring during sleep. This pillow is available at lower costs compared to other anti-snoring pillows in the market. Such developments will stimulate the industry growth.
Furthermore, increase in number of cases for abnormalities of throat like enlarged tonsils resembling swelling and nose abnormalities including deviated nasal septum or nasal polyps causing narrowing of passageway for the air to pass during breathing and sleep will lead to high demand for snore controlling devices. Additionally, growing geriatric population, inappropriate sleep positions will have a positive impact on the market anti-snoring treatment market.
On the contrary, high investment in anti-snoring treatment including devices and surgery along with limited efficacy and mediocre results of current treatment available in the market and unfavorable reimbursement policies would impede the growth for this market.
Sedentary lifestyle and obesity expected to fuel the growth
The sedentary lifestyle is further expected to surge the market. According to World Health Organization (WHO), sedentary lifestyles proves to be fatal for around 5.3 million people every year globally, with minimum 300,000 premature deaths and US$90 billion are spent in directly as healthcare costs to reduce problems caused by obesity and sedentary lifestyle yearly in the U.S. Physical inactivity causes around 2 million deaths every year forcing WHO to issue a warning regarding sedentary lifestyle being among top ten major causes of death and disability around the world. The US Department of Health and Human Service, stated only one in three children are physically active every day in the U.S. Thus, the rising sedentary lifestyle would lead to various sleep disorders and associated problems thereby, enhancing the development and creating opportunities for anti-snoring treatment market.
World Health Organization (WHO) in their report, mentioned the rate of obesity has tripled since 1975 worldwide. 2016 saw over 1.9 billion adults belonging to age group 18 years or above were overweight and out of them, over one-third people were obese. As a result, problems arising due to obesity would create demand for anti-snoring treatment thereby propelling the market growth.
Rising awareness about anti-snoring treatment to create growth opportunities
The number of people suffering with snoring problem worldwide, is quite large, however people accounted for opting for anti-snoring treatments is very low comparatively. In the U.S., around 40 million people suffer from the problems associated with common snoring. But the number of people opting to undergo treatment is mere less than 2%. However, due to the rising awareness regarding the adverse effects of snoring, availability of anti-snoring treatments and technological advancements in anti-snoring products, the anti-snoring devices market is witnessing positive growth. The presence of a large number of untreated population would help the market grow exponentially coupled with emerging economies and untapped markets to provide expansion and growth opportunities to the market in the anti-snoring treatment.
Key benefits of the report:
- This study presents the analytical depiction of the global anti-snoring treatment industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global anti-snoring treatment market share.
- The current market is quantitatively analyzed to highlight the global anti-snoring treatment market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed global anti-snoring treatment market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the anti-snoring treatment market research report:
- Which are the leading market players active in the anti-snoring treatment market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in taking further strategic steps?
Anti-Snoring Treatment Market Report Highlights
| Aspects | Details |
 By Device |
|
 By Surgery Type |
|
 By End User |
|
 By Region |
|
 Key Market Players | Fisher & Paykel Healthcare, Foundation Care,, Airway Management Inc.,, Philips Healthcare,, Apnea Sciences Corporation,, Tomed Dr. Toussaint Gmbh,, The Pure Sleep Company,, GlaxoSmithKline PLC,, Meditas,, Medtronic PLC. |
Loading Table Of Content...
